Daqiang Li

28PUBLICATIONS
50CO-AUTHORS
Molecular targetsPredictive and prognostic markersNanoelectronicsCancer diagnosisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 25, 2026
Enzymatic activity-independent NANS stabilizes LATS2 to drive growth and therapeutic resistance in HR+/HER2- breast cancer.

|Jan 15, 2026
Bisphosphate nucleotidase 1 promotes progression and docetaxel resistance in triple-negative breast cancer via STUB1-mediated destabilization of LIMA1.

Yun-Xiao Ling, Lisa Andriani, Shao-Ying Yang

|Nov 14, 2025
PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis.

Shuang Tang, Qian Zhou, Johann S Bergholz

|Sep 27, 2025
Autophagy-Related Proteins in Triple-Negative Breast Cancer: From Molecular Insights to Therapeutic Applications.

Meng-Ke Ma, Da-Qiang Li

|Jun 23, 2025
MYC/TET3-Regulated TMEM65 Activates OXPHOS-SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple-Negative Breast Cancer.

Yin-Ling Zhang, Min-Ying Huang, Shao-Ying Yang

|Jan 21, 2025
Secernin-2 Stabilizes Histone Methyltransferase KMT2C to Suppress Progression and Confer Therapeutic Sensitivity to PARP Inhibition in Triple-Negative Breast Cancer.

Min-Ying Huang, Jia-Yang Cai, Shao-Ying Yang

Pageof 5

Frequent Collaborators

7 joint publications

Fang-Lin Zhang

3 joint publications

Lisa Andriani

3 joint publications

Shu-Yuan Hu

3 joint publications

Zhi-Ming Shao